Benzinga | Aug 4, 2021 08:38AM EDT

Morgan Stanley Maintains Underweight on Clorox, Lowers Price Target to $160

Morgan Stanley analyst Dara Mohsenian maintains Clorox (NYSE:CLX) with a Underweight and lowers the price target from $170 to $160.